Moody TW, Jensen RT. Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide [Part 1]: biology, pharmacology, and new insights into their cellular basis of action/signaling which are providing new therapeutic targets. Curr Opin Endocrinol Diabetes Obes 2021;28:198-205. [PMID: 33449573 DOI: 10.1097/MED.0000000000000617][Cited by in Crossref: 4][Cited by in F6Publishing: 3][Article Influence: 4.0][Reference Citation Analysis]
Sokolov AY, Osipchuk AV, Skiba IB, Amelin AV. The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis. Neurochem J 2022;16:31-8. [DOI: 10.1134/s1819712422010123][Reference Citation Analysis]